CE

Chetan Ekanath Firake

Active Director Director DIN 05103782
DIN 05103782 First appointment Nov 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2011
Shareholding value •••• Premium profile

About Chetan Ekanath Firake

Data last updated:

Chetan Ekanath Firake is a Director at Medispin Pharmaceutical Private Limited (since 2011). The company operates in Pharma. Medispin Pharmaceutical Private Limited reported revenue of ₹1.35 Cr (FY 2024).

DIN 05103782
Primary Designation Director
Industry Pharma
First Appointment 14 Nov 2011
Oldest Company Age 14 yrs
Largest company Medispin Pharmaceutical Private Limited · ₹1.35 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Nov 20112011₹1.35 Cr (FY 2024)Active

Board colleagues of Chetan Ekanath Firake

Directorship timeline

Open interactive timeline →
Medispin Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Chetan Ekanath Firake

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chetan Ekanath Firake

Chetan Ekanath Firake currently holds 1 directorship: Medispin Pharmaceutical Private Limited (Director, since 14 Nov 2011, revenue ₹1.35 Cr (FY 2024)).

Chetan Ekanath Firake was first appointed on 14 Nov 2011 as Director at Medispin Pharmaceutical Private Limited.

The current boards of Chetan Ekanath Firake's companies include Jaypalsingh Chandrasingh Jamadar (Medispin Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available